US FDA removes REMS requirement for TRYVIO (aprocitentan) – minimizing the burden on the healthcare delivery systems and patients
Ad hoc announcement pursuant to Art. 53 LR FDA confirms that prescribers and pharmacists are no longer expected to interact with the REMS Allschwil, Switzerland – March 17, 2025Idorsia Ltd…
Bureau Veritas renforce sa position de leader sur le marché chilien du cuivre grâce à l’acquisition de GeoAssay
COMMUNIQUE DE PRESSE Paris – 17 mars 2025 Bureau Veritas renforce sa position de leader sur le marché chilien du cuivre grâce à l'acquisition de GeoAssay Bureau Veritas, leader mondial…
EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition
MONT-SAINT-GUIBERT, Belgium, March 17, 2025 (GLOBE NEWSWIRE) -- EsoBiotec SA, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, today announced it has entered…
Publication of the statement from the Board of Directors regarding Constantinsborg A/S’ voluntary cash offer to the shareholders of FirstFarms A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF ANY APPLICABLE LAWS OR REGULATIONS, INCLUDING IN…
12/2025・Trifork Group: Weekly report on share buyback
Company announcement no. 12 / 2025Schindellegi, Switzerland – 17 March 2025 Trifork Group: Weekly report on share buyback On 28 Februay 2025, Trifork initiated a share buyback program in accordance…
Offentliggørelse af bestyrelsens redegørelse vedrørende Constantinsborg A/S’ frivillige kontante købstilbud til aktionærerne i FirstFarms A/S
MÅ IKKE OFFENTLIGGØRES, PUBLICERES ELLER UDLEVERES DIREKTE ELLER INDIREKTE I ELLER TIL NOGEN JURISDIKTION, HVOR DETTE VILLE UDGØRE EN OVERTRÆDELSE AF GÆLDENDE LOVGIVNING ELLER REGLER I DEN PÅGÆLDENDE JURISDIKTION, HERUNDER…
Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of individuals with Types 2 or 3 spinal muscular atrophy (SMA)Late-breaking oral…
Nexans enters into exclusive negotiations with Latour Capital for the sale of Lynxeo
Nexans enters into exclusive negotiations with Latour Capital for the sale of Lynxeo PRESS RELEASE Nexans announces having entered into exclusive negotiations with Latour Capital for the sale of Lynxeo…
Nexans entre en négociations exclusives avec Latour Capital pour la vente de Lynxeo
Nexans entre en négociations exclusives avec Latour Capital pour la vente de Lynxeo _COMMUNIQUE DE PRESSE_ Nexans annonce être entré en négociations exclusives avec Latour Capital pour la vente de…
VEON appoints Johan Buse as the Incoming CEO of Banglalink
Dubai and Dhaka, 17 March 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Group”), today announces that Johan Buse has been appointed as the Chief Executive…